Get the Stockscreener App
13.06
1.28%
-0.17
Rxsight Inc stock is traded at $13.06, with a volume of 880.95K.
It is down -1.28% in the last 24 hours and down -15.80% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$13.23
Open:
$13.21
24h Volume:
880.95K
Relative Volume:
1.02
Market Cap:
$643.83M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-15.93
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
-17.60%
1M Performance:
-15.80%
6M Performance:
-72.80%
1Y Performance:
-78.74%
1-Day Range:
$13.03
$13.59
1-Week Range:
$13.03
$15.82
52-Week Range:
$13.03
$64.50
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
13.06 | 643.83M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
Insiders Who Purchased US$1.42m Of RxSight Stock May Not Have Expected 12% Tumble - simplywall.st
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - Benzinga
RxSight: Favorable Risk/Reward Scenario with Strong Growth Prospects and Attractive Valuation - TipRanks
RxSight (NASDAQ:RXST) Sets New 12-Month Low After Earnings Miss - Defense World
Envestnet Asset Management Inc. Has $210,000 Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. Reports Strong Q1 2025 Revenue Growth - TipRanks
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Rxsight Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: RxSight reports Q1 2025 earnings beat, stock rises 6.67% - Investing.com Nigeria
RxSight, Inc. (RXST) Tops Q1 EPS by 17c - StreetInsider
RxSight, Inc. Reports First Quarter 2025 Financial Results - GlobeNewswire
In the Green: RxSight Inc (RXST) Closes at 13.95, Up/Down -4.71 from Previous Day - DWinneX
RxSight, Inc. (NASDAQ:RXST) Shares Sold by First Trust Advisors LP - Defense World
RxSight’s Earnings Call: Growth Amid Challenges - TipRanks
RxSight (RXST) Expected to Announce Earnings on Wednesday - Defense World
How to Take Advantage of moves in (RXST) - news.stocktradersdaily.com
Prepare Yourself for Liftoff: RxSight Inc (RXST) - Sete News
RxSight Inc (RXST)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
RxSight Inc (RXST) is a good investment, but the stock may be undervalued - uspostnews.com
RxSight, Inc. to Present at the Bank of America Healthcare Conference - The Manila Times
RxSight, Inc. to Present at Bank of America Healthcare Conference on May 14, 2025 - Nasdaq
RxSight Brings Latest Cataract Surgery Innovation Updates to Major Healthcare Conference - Stock Titan
RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Piper Sandler gives a Neutral recommendation for RxSight Inc (RXST) - knoxdaily.com
Russell Investments Group Ltd. Sells 94,412 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
JPMorgan Chase & Co. Reduces Stake in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. (NASDAQ:RXST) Given Average Recommendation of “Hold” by Brokerages - Defense World
RxSight Inc [RXST] Records 50-Day SMA of $23.43 - knoxdaily.com
What Does RxSight, Inc.'s (NASDAQ:RXST) Share Price Indicate? - Yahoo
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 - The Manila Times
RxSight, Leading Eye Surgery Tech Company, Sets Q1 2025 Earnings Release Date - Stock Titan
LPL Financial LLC Boosts Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Geode Capital Management LLC Has $28.57 Million Stock Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
Piper Sandler Initiates Coverage of RxSight (RXST) with Neutral Recommendation - Nasdaq
This Aurora Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - Benzinga
Piper Sandler Initiates RxSight at Neutral With $18 Price Target - marketscreener.com
Piper Sandler Begins Coverage of RxSight (RXST) with Neutral Rat - GuruFocus
Piper Sandler sets RxSight stock target at $18, stays neutral By Investing.com - Investing.com South Africa
Piper Sandler sets RxSight stock target at $18, stays neutral - Investing.com
Piper Sandler Starts RxSight Inc. (RXST) at Neutral - StreetInsider
RxSight price target lowered to $17 from $22 at Wells Fargo - MSN
Midday Stock Roundup: Compass Shares Plummet 57% - Orange County Business Journal
RxSight plunges after guidance cut; BofA downgrades - MSN
RxSight stock plunges to 52-week low at $14.24 amid market challenges By Investing.com - Investing.com South Africa
RxSight stock plunges to 52-week low at $14.24 amid market challenges - Investing.com
UBS cuts RxSight stock rating to neutral, slashes price target to $16 By Investing.com - Investing.com South Africa
RxSight downgraded at UBS after Q1 miss and guidance cut - MSN
RxSight stock downgraded at UBS on guidance cut (RXST:NASDAQ) - Seeking Alpha
Needham Cuts Price Target on RxSight to $22 From $43, Keeps Buy Rating - MarketScreener
UBS Downgrades RxSight to Neutral From Buy, Cuts Price Target to $16 From $45 - MarketScreener
UBS cuts RxSight stock rating to neutral, slashes price target to $16 - Investing.com Australia
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):